11/23/2009

The FDA is evaluating data linking Abbott Laboratories' obesity drug Meridia to an increased risk of heart attack, stroke and other cardiovascular events. The drug has been available since 1997, but the FDA recommends against its use in patients with heart-related conditions.

Full Story:
CNNMoney

Related Summaries